Phase I Study of Indibulin in Patients With Solid Tumors
Dose-finding and pharmacokinetic trial of orally administered Indibulin to patients with solid tumors.
Solid Tumors
DRUG: indibulin
toxicities, 4 months
pharmacokinetics, 4 months
Dose-finding and pharmacokinetic trial of orally administered Indibulin to patients with solid tumors.